FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

SRYBNIK SIMON 		2. Issuer Name and Ticker or Trading Symbol

VASOMEDICAL INC [ VASO.OB ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      __ X __ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

140 53RD STREET 		3. Date of Earliest Transaction (MM/DD/YYYY)

3/16/2010
(Street)

BROOKLYN, NY 11232
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

4/21/2010 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock                  21428572   I   By Kerns Manufacturing Corp.   (1)
Common Stock   3/16/2010     A    7824167   A   (5) 17815007   I   By Living Data Technology Corporation   (2)
Common Stock   3/16/2010     A    60625   A   (6) 498125   D  
 

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
2004 Stock Option/Stock Issuance Plan   $.12   7/26/2007     A      150000         (4) 7/25/2017   Common Stock   150000   $.12   150000   D  
 
Warrant (right to buy)   $.08                    6/21/2007   6/20/2012   Common Stock   4285.714     4285.714   I   By Kerns Manufacturing Corp.   (3)

Explanation of Responses:
( 1)  The reporting person and his brother Louis Srybnik are the sole directors and the Chairman of the Board and the President, respectively, of the record holder of these shares. They also are the sole shareholders of the record holder, each holding 50% of the shares. The reporting person, accordingly, shares with his brother voting and dispositive powers over these shares and, as a result, may be deemed to be the co-beneficial owner thereof.
( 2)  The reporting person and his brother Louis Srybnik are the sole directors and officers of the record holder of these shares. They also each own 35% of the outstanding shares of the record holder. The reporting person, accordingly, shares with his brother voting and dispositive powers over these shares and, as a result, may be deemed to be the co-beneficial owner thereof.
( 3)  See Note (1) as to why the reporting person may be deemed to be the co-beneficial owner of this warrant.
( 4)  Options vest immediately.
( 5)  Shares issued pursuant to the terms of an Amendment to Supplier Agreement between Living Data Technology Corporation and Vasomedical, Inc.
( 6)  Director fees.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
SRYBNIK SIMON
140 53RD STREET
BROOKLYN, NY 11232 		X X


Signatures
/s/ Simon Srybnik 4/22/2010
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Vaso (QX) (USOTC:VASO)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024 Vaso (QX) 차트를 더 보려면 여기를 클릭.
Vaso (QX) (USOTC:VASO)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024 Vaso (QX) 차트를 더 보려면 여기를 클릭.